from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0417/thiG

LFCtreatmentdescriptionclass of inhibitor

-0.931

Amikacinug/mL Amikacintranslation

-0.801

Cap5-10ug/mL Capreomycintranslation

-0.440

Rox10-50 ug/mL Roxithromycintranslation

-1.526

SM2-5 ug/mL Streptomycintranslation

-2.721

Tet5-10 ug/mL Tetracyclinetranslation

0.498

Rif0.2-5ug/mL Rifampicintranscription

0.485

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.069

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.319

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.399

CPZ10-50 ug/mL Chlorpromazinerespiration

0.813

Clofazimine10-13 ug/mL Clofaziminerespiration

0.456

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.308

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.042

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.124

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.641

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.034

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.125

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.537

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.339

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.069

KCN5-20 ug/mL Potassium cyaniderespiration

-0.535

NaN30.2-2 mM Sodium aziderespiration

-0.570

Nigericin50 uM Nigericinrespiration

0.130

TRC10-150 ug/mL Triclosanrespiration

0.569

TRZ10-25 ug/mL Thioridazinerespiration

-1.325

Valinomycin0.5-10 uM Valinomycinrespiration

1.359

ZnSO42 mM ZnSO4respiration

0.094

menadione6-10 ug/mL Menadionerespiration

0.184

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.400

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.441

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.052

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.596

NRP_1Non-replicating persistence stage 1dosRassociated

-0.623

Amp0.2mg/mL AmpicillincellWall

-0.125

Cephalexin20-100 ug/mL CephalexincellWall

0.250

Cerulenin0.32-5 ug/mL CerulenincellWall

0.635

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.188

EMB10-20 ug/mL EthambutolcellWall

-0.107

Eta12-40 ug/mL EthionamidecellWall

-0.444

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.031

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.124

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.355

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.817

BZA0.12 mg/mL BenzamidearomaticAmides

0.902

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.846

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.068

H2O24 mM hydrogen peroxideDNAdamaging

0.012

Levo10 ug/mL LevofloxacinDNAdamaging

-0.086

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.631

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.014

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.198

UVUV-irradiationDNAdamaging

-0.384

ARP41-4 ug/mL Antitubercular compound ARP4?

0.158

Antimycin12.5-50 ug/mL Antimycin A?

-0.037

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.395

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.442

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.135

PA8240.2-2 ug/mL PA-824?

-0.897

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.546

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.755

Verapamil50 uM Verapamil?

-0.432

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.230

methoxatin10-20 ug/mL Methoxatin?